Quest Receives Approval For A(H1N1) Test

Medical devices company Quest Diagnostics' Simplexa influenza A H1N1 (2009) test has been CE-approved and is now available as a test kit for distribution to 35 countries in Europe. BMI believes the approval will reinforce the company's track record of being first-to-market with new laboratory testing services for emerging infectious diseases. It also highlights the increasing investor interest in the medical device company, as shown by its rising share price.

To read the full article, please choose one of the following options: